Recent advances in the development of human rhinovirus 3C protease inhibitors
- 25 February 2001
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 11 (2) , 177-184
- https://doi.org/10.1517/13543776.11.2.177
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Poliovirus‐encoded proteinase 3C: a possible evolutionary link between cellular serine and cysteine proteinase familiesPublished by Wiley ,2001
- Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2000
- Design of rhinovirus protease inhibitors for the treatment of the common coldDrugs of the Future, 2000
- Azodicarboxamides: A New Class of Cysteine Proteinase Inhibitor for Hepatitis A Virus and Human Rhinovirus 3C EnzymesThe Journal of Organic Chemistry, 1999
- Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsBioorganic & Medicinal Chemistry Letters, 1999
- Human rhinovirus 3C protease inhibitors: recent developmentsExpert Opinion on Therapeutic Patents, 1998
- Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C ProteaseJournal of Medicinal Chemistry, 1996
- A consensus sequence for substrate hydrolysis by rhino virus 3C proteinaseFEBS Letters, 1989
- Hydrolysis of a Series of Synthetic Peptide Substrates by the Human Rhinovirus 14 3C Proteinase, Cloned and Expressed in Escherichia coliJournal of General Virology, 1989
- The expression and purification of human rhinovirus protease 3CEuropean Journal of Biochemistry, 1989